DNA 10-Q: SEC filing
Ginkgo Bioworks
Filed with the SEC on · accession 0001628280-26-072290
DNA filed a 10-Q (quarterly report) with the SEC on Nov 9, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved +9.6% by the first close after the filing.
Summary of the filing
Ginkgo Bioworks filed its Q3 2026 Form 10-Q, reporting quarterly financial results and disclosing the completed divestiture of its Ginkgo Biosecurity business unit (Tower Biosecurity Inc./Perimiter) as a discontinued operation.
Key details
How DNA stock reacted
Close before
$11.29
Nov 6, 2026
First close after
+9.57%
$12.37
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for DNA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for DNA?
Click hereFrequently asked questions
What did DNA file with the SEC on Nov 9, 2026?
DNA filed a 10-Q (SEC filing). Ginkgo Bioworks filed its Q3 2026 Form 10-Q, reporting quarterly financial results and disclosing the completed divestiture of its Ginkgo Biosecurity business unit (Tower Biosecurity Inc./Perimiter) as a discontinued operation.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did DNA stock react to this filing?
DNA closed at $11.29 before the filing and $12.37 on Nov 9, 2026 (+9.57%).
Other DNA SEC filings
- 8-K · SEC filingNov 5, 2026
- 8-K · SEC filingOct 29, 2026
- 10-Q · SEC filingAug 6, 2026
- 8-K · SEC filingAug 5, 2026
- 8-K · SEC filingJul 30, 2026
- 8-K · Board changeJun 12, 2026
- 144 · Insider sale plannedJun 10, 2026
- 144 · Insider sale plannedMay 22, 2026
- 144 · Insider sale plannedMay 13, 2026
- 10-Q · SEC filingMay 7, 2026
Get alerts when DNA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days